“Personalized, risk-based screening is critical to improving breast cancer outcomes, and AI tools offer us the best opportunity to fulfill that potential,” said Robert Smith, PhD, senior vice ...

The optimal duration of checkpoint inhibitor immunotherapy is unknown. Pivotal clinical trials typically tested these medications for up to two years, but in practice, some patients continue to use ...

More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has not benefited all patients.

Scientists and advocates for trans rights say the change will make it much harder to understand cancer diagnoses and trends among the trans population.

One day at the office, I developed a dull pain in my right lower abdomen that grew in intensity. I checked into the emergency room. My gallbladder was infected and had to come out. When I was in the ...

Medications used to treat skin melanoma, such as checkpoint inhibitor immunotherapy, do not work as well against uveal melanoma. Kimmtrak, the first drug approved specifically for this type of cancer, ...

Earlier today, W. Kimryn Rathmell, MD, PhD, announced her decision to step down as the 17th Director of the National Cancer Institute (NCI). Dr. Rathmell, who assumed the role on December 18, 2023, ...

The Food and Drug Administration (FDA) approved the first at-home kit for self-collecting samples for cervical cancer screening for people ages 25 to 65 at average risk, according to Teal Health, the ...

Fallopian tube removal during planned abdominal surgeries for post-reprodutive women could save thousands of lives every year.

The original IV infusion formulation of Opdivo is approved for the treatment of 11 different types of cancer. The new injectable formulation is indicated—alone or in combination regimens—for most of ...

Adding the anti-CD38 monoclonal antibody Darzalex Faspro (daratumumab) to a standard first-line regimen of Velcade (bortezomib), Revlimid (lenalidomide) and dexamethasone delayed disease progression ...

Recognizing the value of DPD testing, England’s National Health Service (NHS) will be making the test available nationwide, according to The Guardian. The NHS notes that of the 38,000 people with ...